Overview

Efficacy of XP20B Following Bunionectomy Surgery

Status:
Completed
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if XP20B is an effective treatment for the relief of pain following bunionectomy surgery.
Phase:
Phase 3
Details
Lead Sponsor:
Xanodyne Pharmaceuticals